Company

For Your Beloveds

History

For the future generations,

we will study to provide answers to incurable diseases.

2016 - Present

Establishment of Designed Cells Central Research Institute,
a growth engine for ground-breaking study

  • Patent registration of “Stem cells for dementia therapy” (USA, Europe, China, Australia, Japan)
  • Patent registration of “Stem cells for beauty”
  • Patent registration of “Glaucoma treatment methods”
  • Patent registration of “Stem cells for stroke therapy”
  • Establishment of Designed Cells Co., Ltd.
  • Establishment of Designed Cells Central Research Institute
  • Funding from Daewon Investment Co. and Biotoxtech Inc.
  • Establishment of Qingdao Sinder Designed Stem Cells (QSDSC) China
  • Contract for the establishment of Designed Cells Viet Nam (DCVN)
  • Certification of Quality Management System ISO 9001:2015
  • Patent registration of “Exosome-rich conditioned medium (ERCM) for cosmetics”
  • Patent registration of “Exosome-rich conditioned medium (ERCM) for arthritis therapy”
  • Patent registration of “White rose extracts for skin whitening & wrinkle care” (China)
  • Paper publication of “Stem cell therapy of arthritis”
  • Patent registration of “Nattokinase for thrombolysis”
  • Paper publication of “Stem cells encoding functional genes for stroke therapy”
  • Paper publication of “Stem cells encoding functional genes for Alzheimer’s disease therapy”
  • Funding from ITX-AI Co.
  • M&A with COSON Co.
  • MOA for the establishment of Designed Cells Health Care (DCHC) Iraq
  • Patent submission of “Canine stem cells and exosome-rich conditioned medium (ERCM) for anti-inflammation”
  • Patent submission of “Feline stem cells and exosome-rich conditioned medium (ERCM) for anti-inflammation”
2011 - 2015

Research & development of stem cells and bioactive materials to treat incurable diseases

  • Paper publication of “Stem cells encoding functional genes for dementia therapy”
  • Patent registration of “Stem cells for the dementia therapy”
  • Patent submission of “Stem cells for dementia therapy” (USA, Europe, China, Australia, Japan)
  • Paper publication of “Anti-aging activity of stem cells”
  • Patent submission of “Stem cells for cerebral palsy therapy”
  • Patent submission of “Stem cells for beauty”
  • Patent submission of “Glaucoma treatment methods”
  • Patent submission of “Stem cells for stroke therapy”
  • Paper publication of “Health span-extending activity of stem cells”